Detalhe da pesquisa
1.
The promise and harms of screening for plasma cell dyscrasias.
Br J Haematol
; 200(6): 704-707, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36626939
2.
Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis.
Br J Haematol
; 200(5): 587-594, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36495317
3.
Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study.
Haematologica
; 108(12): 3384-3391, 2023 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37439357
4.
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review.
Eur J Haematol
; 111(3): 491-498, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37382045
5.
Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma.
Eur J Haematol
; 110(6): 626-632, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36752328
6.
Impact of academic medical center access on outcomes in multiple myeloma.
Am J Hematol
; 98(1): 41-48, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36266759
7.
Quality of end-of-life care in multiple myeloma: A 13-year analysis of a population-based cohort in Ontario, Canada.
Br J Haematol
; 199(5): 688-695, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35949180
8.
Palliative care utilization, transfusion burden, and end-of-life care for patients with multiple myeloma.
Eur J Haematol
; 109(5): 559-565, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36054450
9.
Hospitalization at the end of life in patients with multiple myeloma.
BMC Cancer
; 21(1): 339, 2021 Mar 31.
Artigo
Inglês
| MEDLINE | ID: mdl-33789626
10.
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019.
BMC Cancer
; 21(1): 730, 2021 Jun 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34172037
11.
Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple-class relapsed/refractory multiple myeloma (RRMM).
Eur J Haematol
; 107(6): 602-608, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34378251
12.
Use of endpoints in multiple myeloma randomized controlled trials over the last 15 years: A systematic review.
Am J Hematol
; 96(6): 690-697, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33735453
13.
A Critical Appraisal and Targeted Intervention of the Oncology Experience in an Internal Medicine Residency.
J Cancer Educ
; 36(6): 1290-1294, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32445119
14.
Ivosidenib and Azacitidine in IDH1-Mutated AML.
N Engl J Med
; 386(26): 2536, 2022 06 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35767449
15.
Teclistamab in Relapsed or Refractory Multiple Myeloma.
N Engl J Med
; 387(18): 1721-1722, 2022 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36322860
16.
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review.
BMC Cancer
; 20(1): 507, 2020 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32493233
17.
Antibiotic prophylaxis for patients with newly diagnosed multiple myeloma: Systematic review and meta-analysis.
Eur J Haematol
; 104(5): 420-426, 2020 May.
Artigo
Inglês
| MEDLINE | ID: mdl-31880853
18.
Inpatient mortality of patients with multiple myeloma and renal impairment undergoing autologous stem cell transplantation.
Eur J Haematol
; 105(5): 571-577, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32662224
19.
Bilateral subthalmic nucleus deep brain stimulation with microelectrode recordings in the setting of mild inherited hemophilia B: a case report.
Int J Neurosci
; 129(9): 933-935, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-30795708
20.
Common Sense Oncology: outcomes that matter.
Lancet Oncol
; 24(8): 833-835, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37467768